Spain Ascites Market

ID: MRFR/HC/54596-HCR
200 Pages
Satyendra Maurya
Last Updated: March 28, 2026
Spain Ascites Market Research Report: By Type (Transudative Ascites, Exudate Ascites), By Diagnosis (Ultrasound, CT Scan, Laparoscopy, Angiography), By Treatment (Surgeries) andBy End User (Hospitals & Clinics, Ambulatory Surgical Center, Diagnostic Centers)- Forecast to 2035
Spain Ascites Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.44%
2018 Market Size$ 32.25 Million
2024 Market Size$ 48.05 Million
2035 Market Size$ 95.48 Million
Key Players
Roche
Bristol-Myers Squibb
Novartis
Merck
Amgen
Gilead Sciences
Trends
  • Rising Incidence of Liver Diseases
  • Advancements in Diagnostic Techniques
  • Focus on Patient-Centric Care
Opportunities
  • Increasing Aging Population
  • Rising Awareness and Education
  • Technological Advancements in Treatment
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Spain Ascites Market, BY Cause of Ascites (USD Million)
      1. 4.1.1 Cirrhosis
      2. 4.1.2 Heart Failure
      3. 4.1.3 Malignancy
      4. 4.1.4 Infection
    2. 4.2 Spain Ascites Market, BY Diagnosis Method (USD Million)
      1. 4.2.1 Ultrasound
      2. 4.2.2 CT Scan
      3. 4.2.3 Physical Examination
      4. 4.2.4 Liver Biopsy
    3. 4.3 Spain Ascites Market, BY Treatment Type (USD Million)
      1. 4.3.1 Diuretics
      2. 4.3.2 Paracentesis
      3. 4.3.3 Transjugular Intrahepatic Portosystemic Shunt
      4. 4.3.4 Liver Transplantation
    4. 4.4 Spain Ascites Market, BY Patient Demographics (USD Million)
      1. 4.4.1 Age
      2. 4.4.2 Gender
      3. 4.4.3 Underlying Health Conditions
      4. 4.4.4 Socioeconomic Status
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Spain Ascites Market
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Spain Ascites Market
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Roche (CH)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Bristol-Myers Squibb (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Novartis (CH)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Merck (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Amgen (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Gilead Sciences (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 AbbVie (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Sanofi (FR)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Pfizer (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 SPAIN MARKET ANALYSIS BY CAUSE OF ASCITES
    3. 6.3 SPAIN MARKET ANALYSIS BY DIAGNOSIS METHOD
    4. 6.4 SPAIN MARKET ANALYSIS BY TREATMENT TYPE
    5. 6.5 SPAIN MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    6. 6.6 KEY BUYING CRITERIA OF SPAIN ASCITES MARKET
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF SPAIN ASCITES MARKET
    9. 6.9 DRIVERS IMPACT ANALYSIS: SPAIN ASCITES MARKET
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: SPAIN ASCITES MARKET
    11. 6.11 SUPPLY / VALUE CHAIN: SPAIN ASCITES MARKET
    12. 6.12 SPAIN ASCITES MARKET, BY CAUSE OF ASCITES, 2024 (% SHARE)
    13. 6.13 SPAIN ASCITES MARKET, BY CAUSE OF ASCITES, 2024 TO 2035 (USD Million)
    14. 6.14 SPAIN ASCITES MARKET, BY DIAGNOSIS METHOD, 2024 (% SHARE)
    15. 6.15 SPAIN ASCITES MARKET, BY DIAGNOSIS METHOD, 2024 TO 2035 (USD Million)
    16. 6.16 SPAIN ASCITES MARKET, BY TREATMENT TYPE, 2024 (% SHARE)
    17. 6.17 SPAIN ASCITES MARKET, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
    18. 6.18 SPAIN ASCITES MARKET, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
    19. 6.19 SPAIN ASCITES MARKET, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY CAUSE OF ASCITES, 2026-2035 (USD Million)
      2. 7.2.2 BY DIAGNOSIS METHOD, 2026-2035 (USD Million)
      3. 7.2.3 BY TREATMENT TYPE, 2026-2035 (USD Million)
      4. 7.2.4 BY PATIENT DEMOGRAPHICS, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Spain Ascites Market Segmentation

Spain Ascites Market By Cause of Ascites (USD Million, 2022-2035)

  • Cirrhosis
  • Heart Failure
  • Malignancy
  • Infection

Spain Ascites Market By Diagnosis Method (USD Million, 2022-2035)

  • Ultrasound
  • CT Scan
  • Physical Examination
  • Liver Biopsy

Spain Ascites Market By Treatment Type (USD Million, 2022-2035)

  • Diuretics
  • Paracentesis
  • Transjugular Intrahepatic Portosystemic Shunt
  • Liver Transplantation

Spain Ascites Market By Patient Demographics (USD Million, 2022-2035)

  • Age
  • Gender
  • Underlying Health Conditions
  • Socioeconomic Status

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.